[LGND] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -209.68%
YoY- -184.97%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 50,382 66,088 57,419 45,693 72,473 64,835 84,675 -29.19%
PBT 24,140 857 -636 -20,140 -7,026 15,259 33,301 -19.25%
Tax 38,674 453 259 -4,755 -2,058 1,536 2,576 505.58%
NP -14,534 404 -895 -15,385 -4,968 13,723 30,725 -
Tax Rate -160.21% -52.86% - - - -10.07% -7.74% -
Total Cost 64,916 65,684 58,314 61,078 77,441 51,112 53,950 13.09%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -28.85 0.61 -1.56 -33.67 -6.85 21.17 36.29 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.86 0.02 -0.05 -0.92 -0.30 0.82 1.84 -
EPS Diluted -0.86 0.02 -0.05 -0.91 -0.30 0.80 1.79 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.